Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Behind The Scenes: How The Pfizergan Deal Got Done

This article was originally published in Scrip

Executive Summary

The deal to combine Pfizer Inc. and Allergan PLC was the culmination of 16 months of careful negotiations, beginning with a dinner between Ian Read and Brent Saunders in July 2014, well before the company that was then Actavis had even disclosed its interest in merging with Allergan. The tortuous process highlights just how challenging it is to establish a solid union between two big pharmas, not to mention finalize a mega-deal. Pfizer approached Allergan and its predecessor company Actavis two times and walked away before a deal was finally signed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel